We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Designing Better Drugs

News   Apr 26, 2016

 
Designing Better Drugs
 
 
 

RELATED ARTICLES

Single Low-dose of Intravenous Ketamine Relieves Depressive Symptoms With Mild Side Effects

News

National Institutes of Health researchers found that a single, low-dose ketamine infusion was relatively free of side effects for patients with treatment-resistant depression.

READ MORE

Antibody Has the Ability To Halt Progression of Pulmonary Arterial Hypertension

News

Scientists have identified a novel antibody that has the potential to become a new treatment for pulmonary arterial hypertension (PAH). The antibody was found to stop the progress of the disease in rodent and cell models, and reverse the proliferation of cells which cause the arteries to thicken.

READ MORE

Antibody Injection Temporarily Stops Peanut Allergy

News

A new study has provided early evidence that an antibody is a safe, effective and rapid food allergy treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE